Clinical trial
Rosuvastatin for Prevention of Deep Vein Thrombosis in Patients Undergoing Total Knee Replacement Arthroplasty: STOP DVT - A Prospective Randomized Controlled Trial
NCT01021488 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rosuvastatin for Prevention of Deep Vein Thrombosis in Patients Undergoing Total Knee Replacement Arthroplasty: STOP DVT - A Prospective Randomized Controlled Trial
- Lead sponsor
- Hallym University Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2009
- Completion date
- March 31, 2012
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis, prevention, thrombosis, venous